Olaf Kutsch

3.4k citations
67 papers · 2.7k indexed · h-index 27
Topics
HIV Research and Treatment (38 papers)Immune Cell Function and Interaction (26 papers)HIV/AIDS drug development and treatment (15 papers)

In The Last Decade

Olaf Kutsch

66 papers receiving 2.7k citations

Peers

Olaf Kutsch
Comparison fields: 5 of 108
  • Virology 1.4k
  • Immunology 987
  • Infectious Diseases 923
  • Molecular Biology 808
  • Epidemiology 488
Replace Udaykumar Ranga with:
Udaykumar Ranga India
Elizabeth A. Rich United States
Andrew J. Henderson United States
Kurt Vermeire Belgium
Nagadenahalli B. Siddappa United States
John T. West United States
Yan Xu China
Liping Wang China
Sergeï Nekhai United States
Nicole Israël France
Olaf Kutsch relative to Udaykumar Ranga India Udaykumar Ranga's profile →
Citations per field
00.5×
Udaykumar Ranga · 1×
Citations per year

Countries citing papers authored by Olaf Kutsch

Since Specialization
Citations

This map shows the geographic impact of Olaf Kutsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Kutsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Kutsch more than expected).

Fields of papers citing papers by Olaf Kutsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Kutsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Kutsch. The network helps show where Olaf Kutsch may publish in the future.

Co-authorship network of co-authors of Olaf Kutsch

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Kutsch. A scholar is included among the top collaborators of Olaf Kutsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Kutsch. Olaf Kutsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 7
4 28
5 14
6 5
7 10
8 16
9 42
10 22
11 27
12 47
13 10
14 92
15 6
16 55
17 18
18 12
19 18
20 97

About Olaf Kutsch

Olaf Kutsch is a scholar working on Virology, Infectious Diseases and Immunology, having authored 67 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (38 papers), Immune Cell Function and Interaction (26 papers) and HIV/AIDS drug development and treatment (15 papers). The work is most often cited by research in Virology (1.4k citations), Infectious Diseases (923 citations) and Immunology (987 citations). Olaf Kutsch has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include George M. Shaw, David N. Levy, Etty Benveniste, Grace M. Aldrovandi, Frank Wolschendorf, Jae‐Wook Oh, Alexandra Duverger, Avindra Nath, Frédéric Bibollet‐Ruche and Chulhee Choi. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026